2016 AND 2020 PREVALENCE DATA FOR
CHRONIC CHEMICAL INJURY, FIBROMYALGIA AND
MYALGIC ENCEPHALOMYELITIS
Statistics Canada has provided Health Risk Navigation Inc. with the 2016 and 2020 Canadian prevalence data for the health conditions of Chronic Chemical Injury (CCI), Fibromyalgia (FM) and Myalgic Encephalomyelitis (ME). ElectroMagnetic Sensitivity (EMS) is not being monitored by Statistics Canada at this time. Consequently, the prevalence data for EMS has not been included. In a nut shell, in 2020, there were over 1,846,800 people, or over 4.9% of the population of Canada with at least one of these health conditions: 3.5% of the population with Chronic Chemical Injury; 1.8% of the population with Fibromyalgia; and 1.4% of the population with Myalgic Encephalomyelitis.
Some Qualifying Information Regarding The Prevalence Numbers:
-
The estimates are rounded to the nearest 100.
-
Due to rounding, the sum of values for each category may differ from the total.
-
Statistics Canada provided us with the estimate numbers and the percentage of the population for the years 2016 and 2020. Then from that data, we have calculated the change in the number of people with these health conditions over the four years.
-
In some instances, the data sample size was too small for the estimated number of people with the condition to be considered accurate. Therefore, Statistics Canada states that this information must be used with caution. We are denoting those estimates with a red (E).
-
In instances of the data sample size being far too small for the data to be reliable, Statistics Canada did not provide us with any estimate data. We are denoting that with the words “Unreliable Data”.
2016 and 2020 Prevalence of Chronic Chemical Injury (CCI) (called Chemical Injury in this chart)

2016 and 2020 Prevalence of Fibromyalgia (FM)

2016 and 2020 Prevalence of Myalgic Encephalomyelitis (ME)
